Skip to main content

Endocrine Therapy Drugs (ETDs) Market to Witness Growth Owing to Increasing Incidence of Breast Cancer

Endocrine Therapy Drugs Market

The endocrine therapy drugs (ETDs) market comprises drugs that are used for the treatment of breast cancer through blocking the production and function of estrogen hormone. Some key ETDs include tamoxifen, aromatase inhibitors such as anastrozole, letrozole, and exemestane. These drugs play a crucial role in managing breast cancer at different stages by either blocking estrogen receptors or lowering estrogen levels in the body.

The Global Endocrine Therapy Drugs (ETDs) Market is estimated to be valued at US$ 35060.96 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the endocrine therapy drugs (ETDs) market include Johnson & Johnson (US), Procter & Gamble (US), Kimberly-Clark (US), Essity Aktiebolag (publ) (Sweden), Kao Corporation (Japan), Daio Paper Corporation (Japan), Unicharm Corporation (Japan), Premier FMCG (South Africa), Ontex (Belgium), Hengan International Group Company Ltd. (China), Drylock Technologies (Belgium), Natracare LLC (US), First Quality Enterprises, Inc. (US), Bingbing Paper Co., Ltd. (China). Key opportunities in the market include expanding production facilities and focused R&D towards developing novel drugs with improved efficacy and reduced side effects. Growing prevalence of breast cancer worldwide has prompted market players to expand their operations across emerging countries.

Market drivers:

One of the key drivers for Endocrine Therapy Drugs Market Growth is the increasing incidence of breast cancer worldwide. As per WHO estimates, breast cancer accounts for nearly 1 in 4 cancer cases among women globally. Growing awareness about early detection and effective management of breast cancer through endocrine therapies is also expected to boost market revenue over the forecast period.

PEST Analysis

Political: The ETDs market is regulated by governmental bodies that approve new drugs and set pricing and reimbursement policies. Changes in healthcare policies impact the demand for ETDs.

Economic: Economic growth influences healthcare expenditures. Recessions can negatively impact sales as patients prioritize other spending over treatment. Also, income levels determine affordability of premium brands.

Social: Aging populations and rising cancer incidence drive the need for ETDs. Growing health awareness increases diagnosis rates and boosts the market. However, social stigma or misinformation around certain illnesses can affect treatment uptake.

Technological: Advancements in drug delivery systems, targeted therapies, and biomarkers support the development of novel ETDs with greater efficacy and fewer side effects. Technologies for large-scale manufacturing help reduce production costs.

The ETDs market sees concentration of value in developed regions including North America, Western Europe, and Japan, largely attributed to the well-established healthcare infrastructure and higher affordability in these markets. However, developing regions in Asia Pacific and Latin America are witnessing faster growth prospects owing to economic expansion, improving access to healthcare, and growing medical needs of expanding middle-class populations. countries like China, India, Brazil and Mexico present high potential for ETDs manufacturers.

The ETDs industry witnesses geographical concentration of value mostly in developed markets of North America, Western Europe, and Japan due to strong healthcare systems and affordability in these regions. However, developing regions in Asia Pacific and Latin America exhibit rapid market growth on account of improving economic conditions, increasing access to healthcare, and augmenting medical requirements of expanding middle-income groups within countries such as China, India, Brazil and Mexico.

Get more insights on Endocrine Therapy Drugs Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

Labels:

Comments

Post a Comment

Popular posts from this blog

Sustainable Aviation Fuel Market is Set to Witness Significant Growth Due to Stringent Emission Norms

Sustainable Aviation Fuel Market Sustainable aviation fuel, also known as biofuel, refers to jet fuel produced from sustainable feedstocks such as grease, vegetable oils and animal fats. It is mandated to reduce the environmental impact of aviation, with a life cycle carbon footprint up to 80% lower than conventional jet fuel. Governments across regions are adopting policies and targets to promote sustainable aviation fuel uptake among airlines. For instance, the EU aims to reach 2 million tons of sustainable fuel per year by 2030. The global sustainable aviation fuel market is estimated to be valued at US$ 2.37 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the sustainable aviation fuel are Eisai Co., Ltd., Novartis AG, AbbVie Inc. (Allergan Plc.), Adamas Pharmaceuticals, Inc., H. Lundbeck A/S, Biogen, AC Immune, F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited, Johnson & Johnson Services,...
Post a Comment
Read more

Rails to Resilience: Strategies Driving Growth in the Railway Coatings Market

Railway Coatings Market Railway coatings play a critical role in protecting rail infrastructure against corrosion, abrasion, and weathering, thereby extending the lifespan of railway assets and enhancing operational efficiency. The Railway Coatings Market encompasses a diverse range of coatings specifically formulated to meet the unique requirements of rail applications, including coatings for rolling stock, track components, bridges, and stations. As the global rail industry continues to expand and modernize, the demand for high-performance coatings that offer durability, safety, and environmental sustainability is on the rise. The railway coatings market was valued at  US$ 2,334.2 Mn in 2024 , and is expected to exhibit a  CAGR of 5.2% , in terms of revenue, over the forecast period  2024-2031  to reach  US$ 3,497.6 Mn by 2031 . Key Takeaways: The Railway Coatings Market is witnessing steady growth, driven by various factors such as infrastructure development ...
Post a Comment
Read more

The Global Antifoaming Agent Market is poised to Exhibit Strong Growth

Antifoaming Agent Market The antifoaming agent market is fast gaining traction due to increasing industrial usage of chemicals, especially in numerous end-use sectors like pharmaceuticals, pulp & paper, paints & coatings, oil & gas, and food & beverages. Antifoaming agents are chemicals that reduce or suppress the formation of foam in industrial processes. They are widely used as additives to prevent foaming issues in various industrial applications. Commonly used antifoaming agents include silicone-based, oil-based, and water-based defoamers. These agents find usage in processes involving agitation to prevent excessive foaming that can negatively impact manufacturing operations and product quality. The Global Antifoaming Agent Market is estimated to be valued at US$ 6.08 Bn in 2024 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the Global Antifoaming Agent market are BASF, Evonik Industries, Air P...
Post a Comment
Read more